Intra-Cellular Therapies Inc. buy Mizuho
Start price
21.06.24
/
50%
€71.00
Target price
21.06.25
€93.48
Performance (%)
73.24%
End price
22.06.25
-
Summary
This prediction is currently being closed. With a performance of 73.24% the BUY prediction by Mizuho is a big success. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $96.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€90.20
22.04.25
22.04.25
74.47%
23.04.25
23.04.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.30
17.02.24
17.02.24
€76.07
17.02.25
17.02.25
76.05%
18.02.25
18.02.25